The power and potential of artificial intelligence (AI) and machine learning (ML) in the healthcare industry are unparalleled.
Share: email Subscribe
Weekly Top Stories Tue, 05 Sep 2023
We have 27 articles this week, #Globus Medical Completes Merger with #NuVasive.#Zevra Therapeutics to Acquire # Acer Therapeutics, expanding its Rare Disease Portfolio and Adding Commercial Product. #Otsuka Pharmaceutical to Acquire #Mindset Pharma. # Sage Therapeutics Implements Strategic Reorganization to Support Plans for ZURZUVAE™ Commercial Launch and Pipeline Advancement.
Editor's Choice
1. 
 The Self-Driving Clinical Trial: Optimizing Research with AI and ML
2. 
 Banner Health Taps evolved MD to Bring Behavioral Health to Primary Care Sites in Phoenix
3. 
 Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
4. 
 Can Artificial Intelligence Replicate the Human Touch in Healthcare Provision?
5. 
 Quant Health Secures $15M for AI-Powered Clinical Trial Design
Top 10 M&A Transactions
6. 
 Globus Medical Completes Merger with NuVasive
7. 
 Zevra Therapeutics to Acquire Acer Therapeutics, expanding its Rare Disease Portfolio and Adding Commercial Product
8. 
 Otsuka Pharmaceutical to Acquire Mindset Pharma
9. 
 Sage Therapeutics Implements Strategic Reorganization to Support Plans for ZURZUVAE™ Commercial Launch and Pipeline Advancement
10. 
 Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement
11. 
 Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.
12. 
 Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
13. 
 UAE: Pure Health Acquires UK’s Largest Private Healthcare Group for AED 4.4 bn
14. 
 Danaher to acquire Abcam for $24.00 per Share
15. 
 Cybin to Acquire Small Pharma Inc.
Top 4 Venture Funding
16. 
 Better Life Partners Raises $26.5M to Expand Virtual SUD Platform
17. 
 Novo Bolsters Obesity Pipeline with Potential $500M Embark Biotech Buy
18. 
 Tapestry Health Secures $25M Credit Investment
19. 
 FTC Temporarily Withdraws Challenge to $27.8B Amgen-Horizon Deal
Top 4 Partnerships Announcements
20. 
 Headspace & Intermountain’s Castell Form VBC Mental Healthcare Partnership
21. 
 New York Structural Biology Center and Syncell Announce Partnership for Microscopy-Guided Proteomics
22. 
 Ossium Health® and Be the Match® Unveil Partnership to Increase Bone Marrow Transplant Accessibility and Treatment Efficiency
23. 
 FFF Enterprises Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Distributor of YCANTH™, the First FDA Approved Treatment for Molluscum Contagiosum
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us